Trial finds similar five-year outcomes with transcatheter or surgical aortic valve replacement

By | November 9, 2021
New five-year data from the SURTAVI trial found that there was no difference in all-cause mortality or stroke between patients at intermediate surgical risk who had transcatheter aortic valve replacement (TAVR) or surgery.